tiprankstipranks
Trending News
More News >
Beta Bionics, Inc. (BBNX)
NASDAQ:BBNX
US Market

Beta Bionics, Inc. (BBNX) Stock Forecast & Price Target

Compare
13 Followers
See the Price Targets and Ratings of:

BBNX Analyst Ratings

Strong Buy
7Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Beta
Bionics, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BBNX Stock 12 Month Forecast

Average Price Target

$26.43
▲(77.98%Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Beta Bionics, Inc. in the last 3 months. The average price target is $26.43 with a high forecast of $31.00 and a low forecast of $20.00. The average price target represents a 77.98% change from the last price of $14.85.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","21":"$21","32":"$32","15.5":"$15.5","26.5":"$26.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$26.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$20.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,15.5,21,26.5,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.14,12.667692307692308,14.195384615384615,15.723076923076924,17.25076923076923,18.77846153846154,20.306153846153848,21.833846153846153,23.361538461538462,24.88923076923077,26.416923076923077,27.944615384615386,29.472307692307695,{"y":31,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.14,12.316153846153847,13.492307692307692,14.668461538461539,15.844615384615384,17.020769230769233,18.196923076923078,19.373076923076923,20.549230769230768,21.725384615384616,22.90153846153846,24.07769230769231,25.253846153846155,{"y":26.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.14,11.821538461538463,12.503076923076923,13.184615384615386,13.866153846153846,14.547692307692309,15.229230769230771,15.910769230769231,16.592307692307692,17.273846153846154,17.955384615384617,18.636923076923075,19.31846153846154,{"y":20,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.81,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.97,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.14,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$31.00Average Price Target$26.43Lowest Price Target$20.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on BBNX
TipRanks AITipRanks
Not Ranked
TipRanks
$15
Hold
1.01%
Upside
Reiterated
05/13/25
Beta Bionics, Inc. scores well due to strong revenue growth and positive market momentum, despite challenges in profitability and cash flow. The favorable earnings call guidance and cash reserves offer a positive outlook. Technical indicators support a bullish trend, but valuation remains uncertain due to a lack of profitability metrics.
Piper Sandler Analyst forecast on BBNX
Matthew O'BrienPiper Sandler
Piper Sandler
$26
Buy
75.08%
Upside
Reiterated
03/17/25
Piper Sandler Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)
Leerink Partners Analyst forecast on BBNX
Mike KratkyLeerink Partners
Leerink Partners
$28
Buy
88.55%
Upside
Initiated
02/24/25
Beta Bionics initiated with an Outperform at LeerinkBeta Bionics initiated with an Outperform at Leerink
Bank of America Securities Analyst forecast on BBNX
Travis SteedBank of America Securities
Bank of America Securities
$25
Buy
68.35%
Upside
Initiated
02/24/25
Beta Bionics initiated with a Buy at BofABeta Bionics initiated with a Buy at BofA
Stifel Nicolaus Analyst forecast on BBNX
Mathew BlackmanStifel Nicolaus
Stifel Nicolaus
$25
Buy
68.35%
Upside
Initiated
02/24/25
Buy Recommendation for Beta Bionics: Leveraging Untapped Market Opportunities and Innovative Product Differentiation
Lake Street Analyst forecast on BBNX
Brooks O'NeilLake Street
Lake Street
$30
Buy
102.02%
Upside
Initiated
02/24/25
Beta Bionics initiated with a Buy at Lake StreetBeta Bionics initiated with a Buy at Lake Street
Ladenburg Thalmann & Co. Analyst forecast on BBNX
Jeffrey CohenLadenburg Thalmann & Co.
Ladenburg Thalmann & Co.
$31
Buy
108.75%
Upside
Initiated
02/20/25
Beta Bionics initiated with a Buy at LadenburgBeta Bionics initiated with a Buy at Ladenburg
Robert W. Baird Analyst forecast on BBNX
Jeff JohnsonRobert W. Baird
Robert W. Baird
$20
Hold
34.68%
Upside
Initiated
02/19/25
Beta Bionics initiated with a Neutral at BairdBeta Bionics initiated with a Neutral at Baird
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on BBNX
TipRanks AITipRanks
Not Ranked
TipRanks
$15
Hold
1.01%
Upside
Reiterated
05/13/25
Beta Bionics, Inc. scores well due to strong revenue growth and positive market momentum, despite challenges in profitability and cash flow. The favorable earnings call guidance and cash reserves offer a positive outlook. Technical indicators support a bullish trend, but valuation remains uncertain due to a lack of profitability metrics.
Piper Sandler Analyst forecast on BBNX
Matthew O'BrienPiper Sandler
Piper Sandler
$26
Buy
75.08%
Upside
Reiterated
03/17/25
Piper Sandler Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)
Leerink Partners Analyst forecast on BBNX
Mike KratkyLeerink Partners
Leerink Partners
$28
Buy
88.55%
Upside
Initiated
02/24/25
Beta Bionics initiated with an Outperform at LeerinkBeta Bionics initiated with an Outperform at Leerink
Bank of America Securities Analyst forecast on BBNX
Travis SteedBank of America Securities
Bank of America Securities
$25
Buy
68.35%
Upside
Initiated
02/24/25
Beta Bionics initiated with a Buy at BofABeta Bionics initiated with a Buy at BofA
Stifel Nicolaus Analyst forecast on BBNX
Mathew BlackmanStifel Nicolaus
Stifel Nicolaus
$25
Buy
68.35%
Upside
Initiated
02/24/25
Buy Recommendation for Beta Bionics: Leveraging Untapped Market Opportunities and Innovative Product Differentiation
Lake Street Analyst forecast on BBNX
Brooks O'NeilLake Street
Lake Street
$30
Buy
102.02%
Upside
Initiated
02/24/25
Beta Bionics initiated with a Buy at Lake StreetBeta Bionics initiated with a Buy at Lake Street
Ladenburg Thalmann & Co. Analyst forecast on BBNX
Jeffrey CohenLadenburg Thalmann & Co.
Ladenburg Thalmann & Co.
$31
Buy
108.75%
Upside
Initiated
02/20/25
Beta Bionics initiated with a Buy at LadenburgBeta Bionics initiated with a Buy at Ladenburg
Robert W. Baird Analyst forecast on BBNX
Jeff JohnsonRobert W. Baird
Robert W. Baird
$20
Hold
34.68%
Upside
Initiated
02/19/25
Beta Bionics initiated with a Neutral at BairdBeta Bionics initiated with a Neutral at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Beta Bionics, Inc.

1 Month
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
-4.27%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of -4.27% per trade.
3 Months
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+11.50%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +11.50% per trade.
1 Year
Mathew BlackmanStifel Nicolaus
Success Rate
2/3 ratings generated profit
67%
Average Return
+12.33%
reiterated a buy rating 2 months ago
Copying Mathew Blackman's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +12.33% per trade.
2 Years
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+12.33%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +12.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BBNX Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
0
7
8
13
Buy
6
6
6
0
Hold
1
2
2
2
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
7
15
16
15
In the current month, BBNX has received 13 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BBNX average Analyst price target in the past 3 months is 26.43.
Each month's total comprises the sum of three months' worth of ratings.

BBNX Financial Forecast

BBNX Earnings Forecast

Next quarter’s earnings estimate for BBNX is -$0.48 with a range of -$0.70 to -$0.33. The previous quarter’s EPS was -$0.93. BBNX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year BBNX has Preformed in-line its overall industry.
Next quarter’s earnings estimate for BBNX is -$0.48 with a range of -$0.70 to -$0.33. The previous quarter’s EPS was -$0.93. BBNX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year BBNX has Preformed in-line its overall industry.

BBNX Sales Forecast

Next quarter’s sales forecast for BBNX is $19.59M with a range of $19.03M to $20.40M. The previous quarter’s sales results were $17.64M. BBNX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.39% of the time in the same period. In the last calendar year BBNX has Preformed in-line its overall industry.
Next quarter’s sales forecast for BBNX is $19.59M with a range of $19.03M to $20.40M. The previous quarter’s sales results were $17.64M. BBNX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.39% of the time in the same period. In the last calendar year BBNX has Preformed in-line its overall industry.

BBNX Stock Forecast FAQ

What is BBNX’s average 12-month price target, according to analysts?
Based on analyst ratings, Beta Bionics, Inc.’s 12-month average price target is 26.43.
    What is BBNX’s upside potential, based on the analysts’ average price target?
    Beta Bionics, Inc. has 77.98% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BBNX a Buy, Sell or Hold?
          Beta Bionics, Inc. has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Beta Bionics, Inc.’s price target?
            The average price target for Beta Bionics, Inc. is 26.43. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $31.00 ,the lowest forecast is $20.00. The average price target represents 77.98% Increase from the current price of $14.85.
              What do analysts say about Beta Bionics, Inc.?
              Beta Bionics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of BBNX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis